Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories (RTSL) Amortizatization of Intangibles (2019 - 2023)

Rapid Therapeutic Science Laboratories' Amortizatization of Intangibles history spans 5 years, with the latest figure at $53024.0 for Q2 2023.

  • For Q2 2023, Amortizatization of Intangibles rose 109.07% year-over-year to $53024.0; the TTM value through Jun 2023 reached $40838.0, down 96.57%, while the annual FY2021 figure was $1.1 million, N/A changed from the prior year.
  • Amortizatization of Intangibles for Q2 2023 was $53024.0 at Rapid Therapeutic Science Laboratories, up from $30331.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.1 million in Q4 2021 and bottomed at -$584530.0 in Q2 2022.
  • The 5-year median for Amortizatization of Intangibles is $25000.0 (2020), against an average of $131872.0.
  • The largest YoY upside for Amortizatization of Intangibles was 109.07% in 2023 against a maximum downside of 95.16% in 2023.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $12500.0 in 2019, then skyrocketed by 100.0% to $25000.0 in 2020, then surged by 4491.46% to $1.1 million in 2021, then tumbled by 103.7% to -$42517.0 in 2022, then skyrocketed by 224.71% to $53024.0 in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Amortizatization of Intangibles are $53024.0 (Q2 2023), $30331.0 (Q1 2023), and -$42517.0 (Q3 2022).